Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07004673

18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Carotid atherosclerotic plaque rupture is the main cause of ischemic stroke attacks, and early and precise assessment of plaque vulnerability can prevent ischemic stroke. High-resolution MRI can reflect vulnerable plaque features such as thin fibrous caps and large lipid cores, but cannot assess their metabolic information; Fibro-activated proteins (FAPs) of PET are specifically expressed in atherosclerosis and suggest vulnerable plaques by reflecting inflammation-induced fibrosis. The aim of this study was to apply 18F FDG\&68Ga-FAPI PET/MR imaging to investigate the vulnerability of carotid atherosclerotic plaques, to obtain quantitative evaluation indexes of active fibrosis within carotid plaques, and to clarify the PET/MR characteristics of unstable plaques in carotid arteries

Conditions

Timeline

Start date
2025-04-12
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-06-04
Last updated
2026-03-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07004673. Inclusion in this directory is not an endorsement.